By Professor Bruce Neal

Conference Posters

RASMUSSEN D; Frederiksen P; Jatkoe A T; Karsdal A M; Rosenthal N; Neal B; Genovese F; Hansen K M, 2022, 'POS-392 CANAGLIFLOZIN TREATMENT IMPACTS COLLAGEN TYPE III DEGRADATION AND FORMATION IN THE CANAGLIFLOZIN CARDIOVASCULAR ASSESSMENT STUDY (CANVAS)', Vol. 7, pp. S177 - S177, http://dx.doi.org/10.1016/j.ekir.2022.01.414

LI J; NEAL B; HEERSPINK HL; ARNOTT C; CANNON C; AGARWAL R; BAKRIS G; CHARYTAN DM; ZEEUW DD; GREENE TOM; LEVIN A; OH R; POLLOCK CA; WHEELER DC; YAVIN Y; ZHANG H; ZINMAN B; DI TANNA GL; PERKOVIC V; MAHAFFEY KW; JARDINE MEG, 2020, '1130-P: Mediators of the Effects of Canagliflozin (CANA) on Heart Failure (HF) and CV Death in Patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease (CKD)', ELECTR NETWORK, Vol. 69, presented at 80th Scientific Sessions of the American-Diabetes-Association (ADA), ELECTR NETWORK, 12 June 2020 - 16 June 2020, http://dx.doi.org/10.2337/db20-1130-p

Ferrannini E; Baldi S; Scozzaro T; Tesfaye F; Shaw W; Rosenthal N; Mahaffey KW; Neal B; Perkovic V; Hansen MK, 2020, 'The Redox Balance Predicts Both Cardiovascular (CV) and Renal Outcomes in CANVAS', ELECTR NETWORK, Vol. 69, presented at 80th Scientific Sessions of the American-Diabetes-Association (ADA), ELECTR NETWORK, 12 June 2020 - 16 June 2020, http://dx.doi.org/10.2337/db20-139-LB

Zhou Z; Jardine M; Heerspink H; Neuen B; Li Q; Arnott C; Mahaffey K; Perkovic V; Neal B, 2020, 'EFFECTS OF SGLT2 INHIBITORS ON STROKE IN TYPE 2 DIABETES ACCORDING TO BASELINE KIDNEY FUNCTION', Chicago, IL, Vol. 75, pp. 221 - 221, presented at Conference of American-College-of-Cardiology (ACC) / World Congress of Cardiology (WCC), Chicago, IL, 28 March 2020 - 30 March 2020, http://dx.doi.org/10.1016/S0735-1097(20)30848-2

Back to profile page